Metastron (Medi-Physics Inc.)


Welcome to the PulseAid listing for the Metastron drug offered from Medi-Physics Inc.. This Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Medi-Physics Inc.
NON-PROPRIETARY NAME: Strontium Chloride Sr-89
SUBSTANCE NAME: STRONTIUM CHLORIDE SR-89
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-06-18
END MARKETING DATE: 0000-00-00


Metastron HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMetastron from Medi-Physics Inc.
LABELER NAME: Medi-Physics Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mCi/mL)
START MARKETING DATE: 1993-06-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17156-524_c91d3a32-be75-48dc-9cb1-c4df19f4ad10
PRODUCT NDC: 17156-524
APPLICATION NUMBER: NDA020134

Other STRONTIUM CHLORIDE SR-89 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BIO NUCLEONICS INCSTRONTIUM CHLORIDE Sr-89
Medi-Physics Inc.Metastron